Segregation of mtDNA throughout human embryofetal development: m.3243A>G as a model system
Open Access
- 30 November 2010
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 32 (1), 116-125
- https://doi.org/10.1002/humu.21417
Abstract
Mitochondrial DNA (mtDNA) mutations cause a wide range of serious diseases with high transmission risk and maternal inheritance. Tissue heterogeneity of the heteroplasmy rate (“mutant load”) accounts for the wide phenotypic spectrum observed in carriers. Owing to the absence of therapy, couples at risk to transmit such disorders commonly ask for prenatal (PND) or preimplantation diagnosis (PGD). The lack of data regarding heteroplasmy distribution throughout intrauterine development, however, hampers the implementation of such procedures. We tracked the segregation of the m.3243A>G mutation (MT‐TL1 gene) responsible for the MELAS syndrome in the developing embryo/fetus, using tissues and cells from eight carrier females, their 38 embryos and 12 fetuses. Mutant mtDNA segregation was found to be governed by random genetic drift, during oogenesis and somatic tissue development. The size of the bottleneck operating for m.3243A>G during oogenesis was shown to be individual‐dependent. Comparison with data we achieved for the m.8993T>G mutation (MT‐ATP6 gene), responsible for the NARP/Leigh syndrome, indicates that these mutations differentially influence mtDNA segregation during oogenesis, while their impact is similar in developing somatic tissues. These data have major consequences for PND and PGD procedures in mtDNA inherited disorders. Hum Mutat 32:116–125, 2011.This publication has 60 references indexed in Scilit:
- Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA diseaseNature, 2010
- Previous Estimates of Mitochondrial DNA Mutation Level Variance Did Not Account for Sampling Error: Comparing the mtDNA Genetic Bottleneck in Mice and HumansAmerican Journal of Human Genetics, 2010
- URINE HETEROPLASMY IS THE BEST PREDICTOR OF CLINICAL OUTCOME IN THE m.3243A>G mtDNA MUTATIONNeurology, 2009
- The Distribution of Mitochondrial DNA Heteroplasmy Due to Random Genetic DriftAmerican Journal of Human Genetics, 2008
- A Mouse Model of Mitochondrial Disease Reveals Germline Selection Against Severe mtDNA MutationsScience, 2008
- Selection against Pathogenic mtDNA Mutations in a Stem Cell Population Leads to the Loss of the 3243A→G Mutation in BloodAmerican Journal of Human Genetics, 2008
- Strong Purifying Selection in Transmission of Mammalian Mitochondrial DNAPLoS Biology, 2008
- Stability of the m.8993T->G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndromeJournal of Medical Genetics, 2007
- The development of novel quantification assay for mitochondrial DNA heteroplasmy aimed at preimplantation genetic diagnosis of Leigh encephalopathyJournal of Assisted Reproduction and Genetics, 2007
- Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal developmentJournal of Medical Genetics, 2006